Cargando…
A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma
Fast and selective fluorescence imaging for a biomarker to related‐disease diagnosis remains a significant challenge due to complex physical environment. Human carboxylesterase (CE) is expected to be a potential biomarker of hepatocellular carcinoma (HCC) to improve the accuracy of diagnosis. Howeve...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015879/ https://www.ncbi.nlm.nih.gov/pubmed/36651112 http://dx.doi.org/10.1002/advs.202206681 |
_version_ | 1784907291283161088 |
---|---|
author | Wen, Ying Jing, Ning Zhang, Min Huo, Fangjun Li, Zhuoyu Yin, Caixia |
author_facet | Wen, Ying Jing, Ning Zhang, Min Huo, Fangjun Li, Zhuoyu Yin, Caixia |
author_sort | Wen, Ying |
collection | PubMed |
description | Fast and selective fluorescence imaging for a biomarker to related‐disease diagnosis remains a significant challenge due to complex physical environment. Human carboxylesterase (CE) is expected to be a potential biomarker of hepatocellular carcinoma (HCC) to improve the accuracy of diagnosis. However, existing probes for CE has slow response rate and low selectivity. Herein, the amide group is selected as CE‐responsive sites based on the “substrate‐hydrolysis enzymatic reaction” approach. From a series of off–on probes with leave groups in the amide unit, probe J(Fast) is screened with the optimal combination of rapid response rate and high selectivity toward CE. J(Fast) requires only 150 s to reach the maximum fluorescence at 676 nm in the presence of CE and free from the interference of other esterase. Computational docking simulations indicate the shortest distance between the CE and active site of J(Fast) . Cell and in vivo imaging present that the probe can turn on the liver cancer cells and tumor region precisely. Importantly, J(Fast) is allowed to specifically image orthotopic liver tumor rather than metastatic tumor and distinguish human primary liver cancer tissue from adjacent ones. This study provides a new tool for CE detection and promotes advancements in accurate HCC diagnosis. |
format | Online Article Text |
id | pubmed-10015879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100158792023-03-16 A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma Wen, Ying Jing, Ning Zhang, Min Huo, Fangjun Li, Zhuoyu Yin, Caixia Adv Sci (Weinh) Research Articles Fast and selective fluorescence imaging for a biomarker to related‐disease diagnosis remains a significant challenge due to complex physical environment. Human carboxylesterase (CE) is expected to be a potential biomarker of hepatocellular carcinoma (HCC) to improve the accuracy of diagnosis. However, existing probes for CE has slow response rate and low selectivity. Herein, the amide group is selected as CE‐responsive sites based on the “substrate‐hydrolysis enzymatic reaction” approach. From a series of off–on probes with leave groups in the amide unit, probe J(Fast) is screened with the optimal combination of rapid response rate and high selectivity toward CE. J(Fast) requires only 150 s to reach the maximum fluorescence at 676 nm in the presence of CE and free from the interference of other esterase. Computational docking simulations indicate the shortest distance between the CE and active site of J(Fast) . Cell and in vivo imaging present that the probe can turn on the liver cancer cells and tumor region precisely. Importantly, J(Fast) is allowed to specifically image orthotopic liver tumor rather than metastatic tumor and distinguish human primary liver cancer tissue from adjacent ones. This study provides a new tool for CE detection and promotes advancements in accurate HCC diagnosis. John Wiley and Sons Inc. 2023-01-18 /pmc/articles/PMC10015879/ /pubmed/36651112 http://dx.doi.org/10.1002/advs.202206681 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Wen, Ying Jing, Ning Zhang, Min Huo, Fangjun Li, Zhuoyu Yin, Caixia A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma |
title | A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma |
title_full | A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma |
title_fullStr | A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma |
title_full_unstemmed | A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma |
title_short | A Space‐Dependent ‘Enzyme‐Substrate’ Type Probe based on ‘Carboxylesterase‐Amide Group’ for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma |
title_sort | space‐dependent ‘enzyme‐substrate’ type probe based on ‘carboxylesterase‐amide group’ for ultrafast fluorescent imaging orthotopic hepatocellular carcinoma |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015879/ https://www.ncbi.nlm.nih.gov/pubmed/36651112 http://dx.doi.org/10.1002/advs.202206681 |
work_keys_str_mv | AT wenying aspacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT jingning aspacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT zhangmin aspacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT huofangjun aspacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT lizhuoyu aspacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT yincaixia aspacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT wenying spacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT jingning spacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT zhangmin spacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT huofangjun spacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT lizhuoyu spacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma AT yincaixia spacedependentenzymesubstratetypeprobebasedoncarboxylesteraseamidegroupforultrafastfluorescentimagingorthotopichepatocellularcarcinoma |